Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
An immunomodulating peptide with potential to suppress tumour growth and autoimmunity
Levring et al., 2015)
All authors may have stocks/stock options in AstraZeneca
doi: 10.1016/j.cell.2012.02.066 100 Seoane-CollazoPMartnez De MorentinPBFernJDiguezCNogueirasRLpezM
instillation of BPC 157 keeps vessel presentation constant and inhibits these stomach, esophagus, and duodenum lesions, whereas standard agents (atropine, ranitidine, omeprazole) only partially improve vessels and lesions
US$ 22.16
US$ 23.04
US$ 20.33
US$ 20.07
US$ 24.83
